Indeed, we and our collaborators previously found similar differences in kinetics of tumor growth in mice obtained from different vendors and differences in tumor control were significantly amplified when the animals were treated with anti-PDL1, a checkpoint blockade therapy [24]. The gene discussed is CD274; the disease is neoplasm.